José Jimeno

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

Federica Grosso, Robin L. Jones, George D. Demetri et al. · The Lancet Oncology · 2007 · 449 citations

Medicine, Oncology, Surgery +13

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Axel Le Cesne, Jean‐Yves Blay, Ian Judson et al. · Journal of Clinical Oncology · 2005 · 421 citations

Medicine, Oncology, Pharmacology +16

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens et al. · New England Journal of Medicine · 2019 · 389 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients

Alejandro Yovine, M. Riofrio, Jean‐Yves Blay et al. · Journal of Clinical Oncology · 2004 · 310 citations

Medicine, Oncology, Pharmacokinetics +13

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Rocio García‐Carbonero, Jeff Supko, Judith Manola et al. · Journal of Clinical Oncology · 2004 · 293 citations · Full text

Medicine, Oncology, Pharmacology +13